Blood tests for diagnosing Alzheimer's disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project evaluates the effectiveness of new blood-based biomarkers for diagnosing Alzheimer's disease in a general practice setting. Current diagnostic methods like cerebrospinal fluid analysis and PET scans are costly and not widely accessible, making them impractical for routine use. The study aims to determine if these blood tests can reliably differentiate Alzheimer's from other neurodegenerative disorders in a population with a lower prevalence of the disease. By simplifying the diagnostic process, the study hopes to improve patient care and support.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Participants suspected by their GP to have possible dementia, based on history, clinical examination and/or cognitive screening

Exclusion Criteria:

* Lack of capacity for consent as judged by the GP.
* Severe psychiatric disease, use of medication or physical disease that according to the GP may affect participation or likely contribute significantly to the observed cognitive impairment.
* Patients not wanting to be referred to the memory outpatient clinic.

Where it's running

• Stavanger University Hospital
  Stavanger, Norway Recruiting

Study contacts

• Study coordinator: Svein R Kjosavik, MD PhD
• Email: svein.kjosavik@sus.no
• Phone: +4790414252

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns

  This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.

  Recruiting University of Cambridge · Cambridge, CB2 · NCT07786116

• Home-based brain monitoring to assess cognitive decline in older adults

  This study is testing a new home kit that tracks brain activity and sleep in older adults to see if it can help spot signs of cognitive decline.

  Recruiting Bitbrain · Zaragoza, Zaragoza · NCT06993207

• Cohort study on Dampness Syndrome in Traditional Chinese Medicine

  This study is looking at how Dampness Syndrome in Traditional Chinese Medicine might be linked to chronic diseases like diabetes, cancer, and dementia in people aged 35 to 75 over five years.

  Recruiting Guangzhou University of Traditional Chinese Medicine · Guangzhou, Guangdong · NCT05315895

• Using a passive home sensor to find digital signs of brain energy changes from nicotinamide riboside

  This project will try a contact-free home sensor to see if it can detect activity, sleep, and breathing changes related to nicotinamide riboside in people with mild cognitive impairment or mild Alzheimer's.

  Recruiting Mclean Hospital · Belmont, Massachusetts · NCT05245903

• Observational study of dementia in elderly Chinese patients

  This study looks at older Chinese adults with dementia to see how lifestyle and stress affect their condition and to track their cognitive health over time.

  Recruiting Peking Union Medical College Hospital · Beijing · NCT05023564

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.